Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Project Oncology®

Chronic GVHD Care: Identifying and Addressing Unmet Needs

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Related
Comments
  • Overview

    From fibrosis to lack of response to T-cell and B-cell therapies, there are several unmet needs in the management of chronic graft-versus-host disease (GVHD). Fortunately, emerging therapies and multidisciplinary care can help us address the unmet needs of our patients and optimize their outcomes. For even more insights on the unmet needs in chronic GVHD care and how we can address them, tune in to hear Dr. Charles Turck speak with Dr. Doris Ponce, Director of the GVHD Program at the Memorial Sloan Kettering Cancer Center in New York City.

Recommended
Details
Presenters
Related
Comments
  • Overview

    From fibrosis to lack of response to T-cell and B-cell therapies, there are several unmet needs in the management of chronic graft-versus-host disease (GVHD). Fortunately, emerging therapies and multidisciplinary care can help us address the unmet needs of our patients and optimize their outcomes. For even more insights on the unmet needs in chronic GVHD care and how we can address them, tune in to hear Dr. Charles Turck speak with Dr. Doris Ponce, Director of the GVHD Program at the Memorial Sloan Kettering Cancer Center in New York City.

Schedule31 Oct 2024